IOVANCE BIOTHERAPEUTICS, INC. Short-term Investments
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Short-term Investments of $186.91 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2026-08-06
- 2026-06-30: Short-term Investments $186.91M.
- 2026-03-31: Short-term Investments $116.94M.
- 2025-12-31: Short-term Investments $133.90M.
- 2025-09-30: Short-term Investments $142.67M.
| Period end | Short-term Investments |
|---|---|
| 2026-06-30 | $186.91M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $116.94M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $133.90M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $142.67M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $168.71M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $188.04M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $208.09M 10-K · filed 2026-02-24 |
| 2024-09-30 | $233.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $183.86M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $222.01M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $164.98M 10-K · filed 2025-02-27 |
| 2023-09-30 | $93.65M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $20.88M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $82.81M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $240.11M 10-K · filed 2024-02-28 |
| 2022-09-30 | $241.81M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $316.38M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $389.83M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $426.18M 10-K · filed 2023-02-28 |
| 2021-09-30 | $517.86M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $573.61M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $472.20M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $562.11M 10-K · filed 2022-02-24 |
| 2020-09-30 | $645.84M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $611.26M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $193.11M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $293.11M 10-K · filed 2021-02-25 |
| 2019-09-30 | $323.00M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $327.20M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $385.90M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $386.37M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |